Trials / Completed
CompletedNCT00771160
MK0476 Study in Adult Patients With Perennial Allergic Rhinitis (0476-397)(COMPLETED)
MK0476 Phase III Long-term Study -Perennial Allergic Rhinitis-
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 15 Years
- Healthy volunteers
- Not accepted
Summary
A clinical study evaluates the efficacy and safety of MK0476 in adult patients with Perennial Allergic rhinitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | montelukast sodium | Arm 1: montelukast tablet 5 mg, QD. Treatment period is 12-weeks. Arm 2: montelukast tablet 10 mg, QD. Treatment period is 12-weeks. |
Timeline
- Start date
- 2004-09-01
- Primary completion
- 2005-02-01
- Completion
- 2005-02-01
- First posted
- 2008-10-13
- Last updated
- 2024-08-15
Source: ClinicalTrials.gov record NCT00771160. Inclusion in this directory is not an endorsement.